Daniela Pugliese

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 27

Top Topics

Peritoneal Dialysis

Patients With Inflammatory Bowel Disease

Ulcerative Colitis

Top Venues

Journal of clinical medicine

United European gastroenterology journal

International journal of molecular sciences

Journal of personalized medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Marta Vernero, Cristina Bezzio, Davide Giuseppe Ribaldone, Flavio A Caprioli, Massimo Claudio Fantini, Stefano Festa, Fabio S Macaluso, Ambrogio Orlando, Daniela Pugliese, Sara Renna, Antonio Rispo, Edoardo Vincenzo Savarino, Angela Variola, Simone Saibeni, null null
Immune-Mediated Inflammatory Diseases Awareness and Management among Physicians Treating Patients with Inflammatory Bowel Disease: An IG-IBD Survey. Journal of clinical medicine 13 (7) (2024)
Marta Vernero, Cristina Bezzio, Davide Giuseppe Ribaldone, Flavio A Caprioli, Massimo Claudio Fantini, Stefano Festa, Fabio S Macaluso, Ambrogio Orlando, Daniela Pugliese, Sara Renna, Antonio Rispo, Edoardo Vincenzo Savarino, Angela Variola, Simone Saibeni, null null
Immune-Mediated Inflammatory Diseases Awareness and Management among Physicians Treating Patients with Inflammatory Bowel Disease: An IG-IBD Survey. Journal of clinical medicine 13 (7) (2024)
Pierluigi Puca, Ivan Capobianco, Gaetano Coppola, Federica Di Vincenzo, Valentina Trapani, Valentina Petito, Lucrezia Laterza, Daniela Pugliese, Loris Riccardo Lopetuso, Franco Scaldaferri
Cellular and Molecular Determinants of Biologic Drugs Resistance and Therapeutic Failure in Inflammatory Bowel Disease. International journal of molecular sciences 25 (5) (2024)
Laura Maria Minordi, Francesca Bice D'Angelo, Giuseppe Privitera, Alfredo Papa, Luigi Larosa, Lucrezia Laterza, Franco Scaldaferri, Brunella Barbaro, Luigi Carbone, Daniela Pugliese
Crohn's Disease: Radiological Answers to Clinical Questions and Review of the Literature. Journal of clinical medicine 13 (14) (2024)
Pierluigi Puca, Ivan Capobianco, Gaetano Coppola, Federica Di Vincenzo, Valentina Trapani, Valentina Petito, Lucrezia Laterza, Daniela Pugliese, Loris Riccardo Lopetuso, Franco Scaldaferri
Cellular and Molecular Determinants of Biologic Drugs Resistance and Therapeutic Failure in Inflammatory Bowel Disease. International journal of molecular sciences 25 (5) (2024)
Giuseppe Cuccia, Giuseppe Privitera, Federica Di Vincenzo, Lucia Monastero, Laura Parisio, Luigi Carbone, Franco Scaldaferri, Daniela Pugliese
Predictors of Efficacy of Janus Kinase Inhibitors in Patients Affected by Ulcerative Colitis. Journal of clinical medicine 13 (3) (2024)
Laura Maria Minordi, Francesca Bice D'Angelo, Giuseppe Privitera, Alfredo Papa, Luigi Larosa, Lucrezia Laterza, Franco Scaldaferri, Brunella Barbaro, Luigi Carbone, Daniela Pugliese
Crohn's Disease: Radiological Answers to Clinical Questions and Review of the Literature. Journal of clinical medicine 13 (14) (2024)
Giuseppe Cuccia, Giuseppe Privitera, Federica Di Vincenzo, Lucia Monastero, Laura Parisio, Luigi Carbone, Franco Scaldaferri, Daniela Pugliese
Predictors of Efficacy of Janus Kinase Inhibitors in Patients Affected by Ulcerative Colitis. Journal of clinical medicine 13 (3) (2024)
Lucrezia Laterza, Anna Chiara Piscaglia, Stefano Bibbo, Vincenzo Arena, Massimo Brisigotti, Giovanna Fabbretti, Maria Loredana Stefanelli, Valentina Cesario, Rossella Maresca, Andrea Poscia, Daniela Pugliese, Eleonora Gaetani, Alfredo Papa, Giovanni Cammarota, Alessandro Armuzzi, Antonio Gasbarrini, Franco Scaldaferri
Histologic Disease Persists beyond Mucosal Healing and Could Predict Reactivation in Ulcerative Colitis. Journal of personalized medicine 14 (5) (2024)
Laura Maria Minordi, Francesca Bice D'Angelo, Giuseppe Privitera, Alfredo Papa, Luigi Larosa, Lucrezia Laterza, Franco Scaldaferri, Brunella Barbaro, Luigi Carbone, Daniela Pugliese
Crohn's Disease: Radiological Answers to Clinical Questions and Review of the Literature. Journal of clinical medicine 13 (14) (2024)
Pierluigi Puca, Ivan Capobianco, Gaetano Coppola, Federica Di Vincenzo, Valentina Trapani, Valentina Petito, Lucrezia Laterza, Daniela Pugliese, Loris Riccardo Lopetuso, Franco Scaldaferri
Cellular and Molecular Determinants of Biologic Drugs Resistance and Therapeutic Failure in Inflammatory Bowel Disease. International journal of molecular sciences 25 (5) (2024)
Marta Vernero, Cristina Bezzio, Davide Giuseppe Ribaldone, Flavio A Caprioli, Massimo Claudio Fantini, Stefano Festa, Fabio S Macaluso, Ambrogio Orlando, Daniela Pugliese, Sara Renna, Antonio Rispo, Edoardo Vincenzo Savarino, Angela Variola, Simone Saibeni, null null
Immune-Mediated Inflammatory Diseases Awareness and Management among Physicians Treating Patients with Inflammatory Bowel Disease: An IG-IBD Survey. Journal of clinical medicine 13 (7) (2024)
Lucrezia Laterza, Anna Chiara Piscaglia, Stefano Bibbo, Vincenzo Arena, Massimo Brisigotti, Giovanna Fabbretti, Maria Loredana Stefanelli, Valentina Cesario, Rossella Maresca, Andrea Poscia, Daniela Pugliese, Eleonora Gaetani, Alfredo Papa, Giovanni Cammarota, Alessandro Armuzzi, Antonio Gasbarrini, Franco Scaldaferri
Histologic Disease Persists beyond Mucosal Healing and Could Predict Reactivation in Ulcerative Colitis. Journal of personalized medicine 14 (5) (2024)
Ahmad Albshesh, Lian Bannon, Tali Sharar Fischler, Marie Truyens, Stephan R Vavricka, Katja Tepes, Daniela Pugliese, Edoardo Vincenzo Savarino, Eran Zittan, David Drobne, Xavier Roblin, Ariella Bar-Gil Shitrit, Alessandro Armuzzi, Triana Lobaton, Nitsan Maharshak, Henit Yanai, Shomron Ben-Horin, Uri Kopylov
Comparison of Short- and Long-Term Effectiveness between Anti-TNF and Ustekinumab after Vedolizumab Failure as First-Line Therapy in Crohn's Disease: A Multi-Center Retrospective Cohort Study. Journal of clinical medicine 12 (7) (2023)
Loris Riccardo Lopetuso, Lucrezia Laterza, Valentina Petito, Silvia Pecere, Gianluca Quaranta, Federica Del Chierico, Pierluigi Puca, Elisa Schiavoni, Daniele Napolitano, Andrea Poscia, Gianluca Ianiro, Daniela Pugliese, Lorenza Putignani, Sanguinetti Maurizio, Alessandro Armuzzi, Luca Masucci, Antonio Gasbarrini, Giovanni Cammarota, Franco Scaldaferri
Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study. Microorganisms 11 (10) (2023)
Daniela Pugliese, Sara Onali, Giuseppe Privitera, Alessandro Armuzzi, Claudio Papi
Comparative Effectiveness Research: A Roadmap to Sail the Seas of IBD Therapies. Journal of clinical medicine 11 (22) (2022)
Stefano Festa, Maria Lia Scribano, Daniela Pugliese, Cristina Bezzio, Mariabeatrice Principi, Davide Giuseppe Ribaldone, Mariangela Allocca, Giammarco Mocci, Giorgia Bodini, Rocco Spagnuolo, Piero Vernia, Silvia Mazzuoli, Francesco Costa, Brigida Barberio, Rocco Cosintino, Giulia Zerboni, Annalisa Aratari, Alessandro Armuzzi, Claudio Papi
Long-term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study. United European gastroenterology journal 9 (4) (2021)
Daniela Pugliese, Giuseppe Privitera, Francesca Rogai, Angela Variola, Anna Viola, Lucrezia Laterza, Antonino C Privitera, Mariangela Allocca, Fabrizio Bossa, Maria Cappello, Marco Daperno, Greta Lorenzon, Silvia Mazzuoli, Mariabeatrice Principi, Renato Sablich, Luisa Moser, Antonio Ferronato, Sara Traini, Gherardo Tapete, Giorgia Bodini, Maria Di Girolamo, Laurino Grossi, Giammarco Mocci, Chiara Ricci, Simone Saibeni, Stefano Festa, Rocco Spagnuolo, Claudio C Cortelezzi, Filippo Mocciaro, Fernando Rizzello, Alessandro Armuzzi, null null
Two-year effectiveness and safety of golimumab in ulcerative colitis: An IG-IBD study. United European gastroenterology journal 9 (1) (2021)
Daniela Pugliese, Alessandro Armuzzi
Difference in treatment outcomes between clinical trials and "real-life" clinical practice: ustekinumab in ulcerative colitis. United European gastroenterology journal 8 (1) (2021)
Daniela Pugliese, Alessandro Armuzzi
Editorial: withdrawal of anti TNF-alpha - are we ready for biological therapy cycling? Alimentary pharmacology & therapeutics 54 (1) (2021)
Franco Scaldaferri, Daniela Pugliese, Giuseppe Privitera, Sara Onali, Loris Riccardo Lopetuso, Gianenrico Rizzatti, Carlo Romano Settanni, Marco Pizzoferrato, Elisa Schiavoni, Laura Turchini, Valeria Amatucci, Daniele Napolitano, Tiziana Bernabei, Vincenzina Mora, Lucrezia Laterza, Alfredo Papa, Luisa Guidi, Gian Lodovico Rapaccini, Antonio Gasbarrini, Alessandro Armuzzi
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre. United European gastroenterology journal 8 (7) (2020)
Simone Saibeni, Ludovica Scucchi, Gabriele Dragoni, Cristina Bezzio, Agnese Miranda, Davide Giuseppe Ribaldone, Angela Bertani, Fabrizio Bossa, Mariangela Allocca, Andrea Buda, Gianmarco Mocci, Alessandra Soriano, Silvia Mazzuoli, Lorenzo Bertani, Flavia Baccini, Erika Loddo, Antonino Carlo Privitera, Alessandro Sartini, Angelo Viscido, Laurino Grossi, Valentina Casini, Viviana Gerardi, Marta Ascolani, Mirko Di Ruscio, Giovanni Casella, Edoardo Savarino, Davide Stradella, Rossella Pumpo, Claudio Camillo Cortelezzi, Marco Daperno, Valeria Ciardo, Olga Maria Nardone, Flavio Caprioli, Giovanna Vitale, Maria Cappello, Michele Comberlato, Patrizia Alvisi, Stefano Festa, Michele Campigotto, Giorgia Bodini, Paola Balestrieri, Anna Viola, Daniela Pugliese, Alessandro Armuzzi, Massimo C Fantini, Gionata Fiorino, null null
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care. United European gastroenterology journal 8 (10) (2020)
Daniela Pugliese, Luisa Guidi, Giuseppe Privitera, Lorenzo Bertani, Barbara Tolusso, Luigi Giovanni Papparella, Simona Maltinti, Clara Di Mario, Sara Onali, Linda Ceccarelli, Gian Lodovico Rapaccini, Franco Scaldaferri, Elisa Gremese, Antonio Gasbarrini, Francesco Costa, Alessandro Armuzzi
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients. Expert opinion on biological therapy 21 (1) (2020)
Luisa Guidi, Daniela Pugliese, Tommaso Panici Tonucci, Lorenzo Bertani, Francesco Costa, Giuseppe Privitera, Barbara Tolusso, Clara Di Mario, Eleonora Albano, Gherardo Tapete, Elisa Gremese, Alfredo Papa, Antonio Gasbarrini, Gian Ludovico Rapaccini, Alessandro Armuzzi
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease. United European gastroenterology journal 7 (9) (2019)
Carla Felice, Daniela Pugliese, Alessandro Armuzzi
The role of healthcare providers in accompanying biosimilars in inflammatory bowel diseases. Expert opinion on biological therapy 19 (10) (2019)
Daniela Pugliese, Luisa Guidi, Giuseppe Privitera, Alessandro Armuzzi
Real-word incidence of inflammatory bowel disease among patients with other chronic inflammatory diseases treated with interleukin-17a or phosphodiesterase 4 inhibitors. Current medical research and opinion 36 (1) (2019)
Daniela Pugliese, Annalisa Aratari, Stefano Festa, Pietro Manuel Ferraro, Rita Monterubbianesi, Luisa Guidi, Maria Lia Scribano, Claudio Papi, Alessandro Armuzzi
Sustained Clinical Efficacy and Mucosal Healing of Thiopurine Maintenance Treatment in Ulcerative Colitis: A Real-Life Study. Gastroenterology research and practice 2018 (2018)